Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px

Document › Details

Ablynx N.V.. (7/6/17). "Press Release: Publication in Accordcance with Article 14 of the Belgian Law of 2 May 2007 Regarding the Publication of Major Shareholdings (the »Transparancy Law«) [Bank of America Corporation]". Ghent.

	Organisation	Ablynx N.V. (Euronext Brussels: ABLX, Nasdaq: ABLX)
	Group	Sanofi (Group) [since May 2011]
	Organisation 2	Merrill Lynch Professional Clearing Corp.
	Group	Bank of America (BofA) (Group)
	Product	investment banking
	Product 2	Nanobodies® (Ablynx)
	Index term	Ablynx–Bank of America: investment, 201707 DIVESTMENT shareholding of Merrill Lynch drops from 5.24% to 4.97%
	Person	Moses, Edwin (Ablynx 200603– CEO before non-exec Board Member 200411– before Oxford Asymmetry)
	Person 2	Vanneste, Lies (Ablynx 201705 Director Invesor Relations)

Original document
accessed by [iito] on 2017-07-27

Record changed: 2023-06-05

Picture EBD Group Startup Spotlight at BIO-Europe 2023 650x200px

More documents for Sanofi (Group) [since May 2011]

[1] Sanofi S.A.. (3/13/23). "Press Release: Sanofi to Acquire Provention Bio, Adding to Portfolio TZIELD, the First Disease-modifying Treatment for the Delay of Stage 3 Type 1 Diabetes (T1D)". Paris & Red Bank, NJ....
[2] Avilar Therapeutics, Inc.. (2/16/23). "Press Release: Avilar Therapeutics Increases Financing to $75 Million to Advance Pipeline of Novel Extracellular Protein Degraders". Waltham, MA....
[3] Sanofi S.A.. (1/11/23). "Press Release: Sanofi Ventures Announces Multi-year Capital Commitment from Sanofi, Increasing Evergreen Fund to $750M". Paris....
[4] CureVac N.V.. (1/10/23). "Press Release: CureVac Appoints Alexander Zehnder as CEO from April 1, 2023". Mainz & London....
[5] Insilico Medicine. (11/8/22). "Press Release: Insilico Medicine Signs Strategic Research Collaboration with Sanofi Worth up to $1.2 Billion". New York, NY....
[6] Matchpoint Therapeutics, Inc.. (10/14/22). "Press Release: Matchpoint Therapeutics Launches with $100 Million to Deliver on the Promise of Precision Covalent Medicines for Immune Diseases". Cambridge, MA....
[7] Owkin. (10/4/22). "Press Release: Owkin Appoints Sanofi’s Global Head of Partnering Alban de La Sablière as Chief Business Officer"....
[8] Sanofi S.A.. (8/4/22). "Press Release: Sanofi and Innovent Biologics Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China". Paris....
[9] BeiGene, Ltd.. (7/13/22). "Press Release: BeiGene Appoints Chan Lee as General Counsel". Cambridge, MA, Basel & Beijing....
[10] Glycomine, Inc.. (7/11/22). "Press Release: Glycomine Appoints Steven Axon as CEO and Adds Two New Board Directors". San Carlos, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]